Insulin-like growth factor (IGF)-I and IGF binding proteins axis in diabetes mellitus
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Increasing evidence suggests an important role of the insulin-like growth factor (IGF)-IGF binding protein (IGFBP) axis in the maintenance of normal glucose and lipid metabolism. Significant changes occur in the local IGF-I-IGFBPs environment in response to the diabetic milieu. A significant reduction of serum IGF-I levels was observed in patients with type 1 diabetes mellitus (T1DM). Inversely, considerably increased serum levels of IGF-I and IGFBP-3 levels were detected in individuals with glucose intolerance including T2DM. Recently, several prospective studies indicated that baseline levels of IGF-I and IGFBPs are associated with the development of diabetes. These findings suggest that disturbances in insulin and IGF-I-IGFBP axis can affect the development of glucose intolerance including diabetes.
Abstract
Increasing evidence suggests an important role of the insulin-like growth factor (IGF)-IGF binding protein (IGFBP) axis in the maintenance of normal glucose and lipid metabolism. Significant changes occur in the local IGF-I-IGFBPs environment in response to the diabetic milieu. A significant reduction of serum IGF-I levels was observed in patients with type 1 diabetes mellitus (T1DM). Inversely, considerably increased serum levels of IGF-I and IGFBP-3 levels were detected in individuals with glucose intolerance including T2DM. Recently, several prospective studies indicated that baseline levels of IGF-I and IGFBPs are associated with the development of diabetes. These findings suggest that disturbances in insulin and IGF-I-IGFBP axis can affect the development of glucose intolerance including diabetes.
참고문헌 (44)
- Daughaday WH., "The possible autocrine", paracrine and endocrine roles of insulin-like growth factors of human tumors, 1990, pp.127, 1~4
- Ullrich A, "Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity", EMBO J, 5, pp.2503~2512 (1986)
- Clemmons DR., "Involvement of insulin-like growth factor-I in the control of glucose homeostasis", Curr Opin Pharmacol, 6, pp.620~625 (2006)
- Le Roith D., "Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors", N Engl J Med, 336, pp.633~640 (1997)
- Baxter RC, "Binding proteins for the insulin-like growth factors: structure, regulation and function", Prog Growth Factor Res, 1, pp.49~68 (1989)
- Jones JI, "Insulin-like growth factors and their binding proteins: biological actions", Endocr Rev, 16, pp.3~34 (1995)
- Jogie-Brahim S, "Unraveling insulin-like growth factor binding protein-3 actions in human disease", Endocr Rev, 30, pp.417~437 (2009)
- Walker GE, "Insulin-like growth factors", pp.1~22 (2004), Landes Biosciences
- Moses AC, "Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes", Diabetes, 45, pp.91~100 (1996)
- Scavo LM, "Insulin-like growth factor-I stimulates both cell growth and lipogenesis during differentiation of human mesenchymal stem cells into adipocytes", J Clin Endocrinol Metab, 89, pp.3543~3553 (2004)
- Laager R, "Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans", J Clin Invest, 92, pp.1903~1909 (1993)
- Jacob R, "Acute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat. Comparison with insulin", J Clin Invest, 83, pp.1717~1723 (1989)
- Sesti G, "Plasma concentration of IGF-I is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance", Diabetes Care, 28, pp.120~125 (2005)
- Russell-Jones DL, "A comparison of the effects of IGF-I and insulin on glucose metabolism, fat metabolism and the cardiovascular system in normal human volunteers", Eur J Clin Invest, 25, pp.403~411 (1995)
- Katz LE, "Free and total insulin-like growth factor (IGF)-I levels decline during fasting: relationships with insulin and IGF-binding protein-1", J Clin Endocrinol Metab, 87, pp.2978~2983 (2002)
- Luo J, "Differential expression of the insulin-like growth factor binding proteins in spontaneously diabetic rats", J Mol Endocrinol, 8, pp.155~163 (1992)
- Lang CH, "Acute in vivo elevation of insulin-like growth factor (IGF) binding protein-1decreases plasma free IGF-I and muscle protein synthesis", Endocrinology, 144, pp.3922~3933 (2003)
- Manetta J, "Effect of training on the GH", IGF-I axis during exercise in middle-aged men: relationship to glucose homeostasis, 2002, pp.283, E929~E936
- Muzumdar RH, "Central and opposing effects of IGF-I and IGF-binding protein-3 on systemic insulin action", Diabetes, 55, pp.2788~2796 (2006)
- Schedlich LJ, "Nuclear import of insulin-like growth factorbinding protein-3 and -5 is mediated by the importin beta subunit", J Biol Chem, 275, pp.23462~23470 (2000)
- Silha JV, "Impaired glucose homeostasis in insulin-like growth factor-binding protein-3-transgenic mice", Am J Physiol Endocrinol Metab, 283, pp.E937~E945 (2002)
- Pratipanawatr T, "Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects", Am J Physiol Endocrinol Metab, 282, pp.E1360~E1368 (2002)
- Laager R, "Effects of recombinant human insulinlike growth factor I and insulin on counterregulation during acute plasma glucose decrements in normal and type 2 (non-insulin-dependent) diabetic subjects", Diabetologia, 36, pp.966~971 (1993)
- Turkalj I, "Effect of increasing doses of recombinant human insulin-like growth factor-I on glucose, lipid, and leucine metabolism in man", J Clin Endocrinol Metab, 75, pp.1186~1191 (1992)
- Laughlin GA, "The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study", J Clin Endocrinol Metab, 89, pp.114~120 (2004)
- Sandhu MS, "Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study", Lancet, 359, pp.1740~1745 (2002)
- Dunger DB, "Does recombinant insulin-like growth factor I have a role in the treatment of insulin-dependent diabetes mellitus during adolescence?", Acta Paediatr Suppl, 388, pp.49~52 (1993)
- Boni-Schnetzler M, "Insulin regulates insulin-like growth factor I mRNA in rat hepatocytes", Am J Physiol, 260(6 Pt 1), pp.E846~E851 (1991)
- Brismar K, "Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes", J Clin Endocrinol Metab, 79, pp.872~878 (1994)
- Holt RI, "The role of the growth hormone-insulin-like growth factor axis in glucose homeostasis", Diabet Med, 20, pp.3~15 (2003)
- Murphy LJ., "The role of the insulin-like growth factors and their binding proteins in glucose homeostasis", Exp Diabesity Res, 4, pp.213~224 (2003)
- Rajpathak SN, "The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes", Diabetes Metab Res Rev, 25, pp.3~12 (2009)
- Frystyk J, "Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes", Diabetes Metab Res Rev, 15, pp.314~322 (1999)
- Rajpathak SN, "Insulin-like growth factor axis and risk of type 2 diabetes in women", Diabetes, 61, pp.2248~2254 (2012)
- Munoz MT, "Insulin-like growth factor I, its binding proteins 1 and 3, and growth hormonebinding protein in children and adolescents with insulindependent diabetes mellitus: clinical implications", Pediatr Res, 39, pp.992~998 (1996)
- Gambaro G, "Growth factors and the kidney in diabetes mellitus", Crit Rev Clin Lab Sci, 35, pp.117~151 (1998)
- Kanazawa I, "Serum insulinlike growth factor-I is negatively associated with serum adiponectin in type 2 diabetes mellitus", Growth Horm IGF Res, 21, pp.268~271 (2011)
- Dunger DB, "Childhood and adolescent diabetes", Endocr Dev, 9, pp.107~120 (2005)
- Cinaz P, "Serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in children with insulin-dependent diabetes mellitus", J Pediatr Endocrinol Metab, 9, pp.475~482 (1996)
- Wedrychowicz A, "Insulin-like growth factor-1 and its binding proteins, IGFBP-1 and IGFBP-3, in adolescents with type-1 diabetes mellitus and microalbuminuria", Horm Res, 63, pp.245~251 (2005)
- Bereket A, "Insulin-like growth factor binding protein-3 proteolysis in children with insulin-dependent diabetes mellitus:a possible role for insulin in the regulation of IGFBP-3protease activity", J Clin Endocrinol Metab, 80, pp.2282~2288 (1995)
- Kim MS, "Serum insulin-like growth factor-binding protein-3 level correlated with glycemic control and lipid profiles in children and adolescents with type 1 diabetes", J Pediatr Endocrinol Metab, 27, pp.857~861 (2014)
- Payne JF, "Serum insulin-like growth factor-I in diabetic retinopathy", Mol Vis, 17, pp.2318~2324 (2011)
- Kim MS, "Clinical characteristics of type 2 diabetes in children identified by school urine glucose screening", Program and Abstract, the 8th Congress of Asian Society for Pediatric Research, 180 (2012), Asian Society for Pediatric Research
